Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(3): 524-536. doi: 10.34172/apb.2024.038
PMID: 39494248        PMCID: PMC11530887

Review Article

Functionalized and Theranostic Lipidic and Tocosomal Drug Delivery Systems: Potentials and Limitations in Cancer Photodynamic Therapy

Fahime Nasr Esfahani 1 ORCID, Sahand Karimi 2, Zahra Jalilian 1, Mehran Alavi 2 * ORCID, Bushra Aziz 3, Enam Alhagh Charkhat Gorgich 4, M. R. Mozafari 1 ORCID, Elham Taghavi 5, Sargol Aminnezhad 6 * ORCID, Sara Ataei 7

Cited by CrossRef: 1

1- Joshi S, Moody A, Budthapa P, Gurung A, Gautam R, Sanjel P, Gupta A, Aryal S, Parajuli N, Bhattarai N. Advances in Natural-Product-Based Fluorescent Agents and Synthetic Analogues for Analytical and Biomedical Applications. Bioengineering. 2024;11(12):1292 [Crossref]
2- Liu X, Zeng T, Zhang E, Bin C, Liu Q, Wu K, Luo Y, Wei S. Plant-based bioactives and oxidative stress in reproduction: anti-inflammatory and metabolic protection mechanisms. Front Nutr. 2025;12 [Crossref]
3- Azimizonuzi H, Ghayourvahdat A, Ahmed M, Kareem R, Zrzor A, Mansoor A, Athab Z, Kalavi S. A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis. Cancer Cell Int. 2025;25(1) [Crossref]
4- Atrooz O, Kerdari E, Mozafari M, Reihani N, Asadi A, Torkaman S, Alavi M, Taghavi E. A Comparative Review of Tocosomes, Liposomes, and Nanoliposomes as Potent and Novel Nanonutraceutical Delivery Systems for Health and Biomedical Applications. Biomedicines. 2024;12(9):2002 [Crossref]
5- Ma Z, Han Z, Wan M, Wang Z, Gao M, Zhao Y, Sun L. Development of a pH/NIR/temperature-responsive drug delivery system using AuNRs@ZnO@mPDA nanoparticles for synergistic cancer therapy. Surfaces and Interfaces. 2025;61:106153 [Crossref]
6- Swain A, Jena S, Samanta L. Smart nanocarriers for cancer: harnessing exosomes and lipid systems in photodynamic and immunotherapy. Front Immunol. 2025;16 [Crossref]